US 10881086
Genetically modified mouse whose genome comprises a humanized CD274 gene
granted A61KA61K2039/505A61K49/0008
Quick answer
US patent 10881086 (Genetically modified mouse whose genome comprises a humanized CD274 gene) held by REGENERON PHARMACEUTICALS, INC. expires Mon Dec 31 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Jan 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 31 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K2039/505, A61K49/0008, A61P, A61P35/00